Eighteenpercent of undifferentiated tumors (tumor grade 3, N = 17) and 16% of tumors from patients with any residual disease(N = 15) were positive for BRCA1 DNA-methylation (P = 0.004, and P = 0.013;respectively; Table 1). Here, BRCA1 is linked to neoplasm.